Medtronic PLC (MDT) — 10-Q Filings

All 10-Q filings from Medtronic PLC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Medtronic Q2 Sales Jump 6.6%, Net Income Up 8.2% Amid Diabetes Spinoff Plans — Nov 25, 2025 Risk: medium
Medtronic plc reported a robust financial performance for the three and six months ended October 24, 2025. Net sales for the three-month period increased by 6.6
Medtronic Sales Jump 8.4%, Diabetes Spinoff Looms — Aug 26, 2025 Risk: medium
Medtronic plc reported net sales of $8,578 million for the three months ended July 25, 2025, an increase of 8.4% from $7,915 million in the prior-year period. N
Medtronic Q3 FY25 10-Q Filed — Feb 25, 2025 Risk: low
Medtronic plc filed its 10-Q for the period ending January 24, 2025, reporting on its financial performance for the third quarter of fiscal year 2025. The filin
Medtronic plc Files 10-Q for Q2 2025 — Nov 26, 2024 Risk: low
Medtronic plc filed its 10-Q for the period ending October 25, 2024, reporting on its financial performance. The filing details various financial instruments an
Medtronic plc Files Q1 FY25 10-Q Report — Aug 27, 2024 Risk: low
Medtronic plc filed its 10-Q for the period ending July 26, 2024. The filing covers the first quarter of fiscal year 2025. Key financial details and operational
Medtronic plc Files 10-Q for Period Ending January 26, 2024 — Feb 27, 2024 Risk: medium
Medtronic plc (MDT) filed a Quarterly Report (10-Q) with the SEC on February 27, 2024. Medtronic plc filed a 10-Q report for the period ending January 26, 2024.

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX